Sino Biological Recombinant Omicron BA5 and BA4 Antigens

FDA Clearance for Spectra™ MRSA Chromogenic Medium

Thermo Fisher Scientific Inc. has received FDA clearance for Spectra™ MRSA, with the highest Positive Predictive Value commercially available for MRSA screening, Spectra provides accurate results within 24 hours. The Spectra MRSA test is manufactured, distributed and sold under the Thermo Fisher specialty brand, Remel.

Spectra™ MRSA is a selective chromogenic medium intended for use in the detection of nasal colonization of methicillin-resistant Staphylococcus aureus. The easy-to-use, easy-to-read format enables cost-effective MRSA testing with final results within 24 hours, seven days a week. Spectra™ MRSA is the clear choice for screening more patients on more shifts in more hospitals.
  • Exceptional performance with a Positive Predictive Value of 98.1%

  • Easy-to-read denim blue colonies on a white background

  • Simple procedure and interpretation adaptable on all shifts

  • Labor saving, cost-effective method for an economical MRSA solution

  • Requires no special handling for optimal workflow 24/7

NOTE: This item is from our 'historic' database and may contain information which is not up to date.

Source : Remel Inc. View Company Information

Posted on April 24, 2008